Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study Waived Parthika Patel31 July 2025 1:49 PM ISTNew Delhi: Zydus Lifesciences Limited has been directed to conduct a Phase III clinical trial in the Indian population for its proposed oncology drug...
CDSCO Introduces QR Code System for Streamlined Visitor Entry Parthika Patel30 July 2025 3:53 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has launched a new QR code-based online appointment system to simplify the process...
Ranitidine Under Cancer Cloud: CDSCO Calls for Monitoring NDMA Levels, Shelf Life Cuts Parthika Patel28 July 2025 6:27 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a directive to all...
Expert Committee Clears Ravenbhel to Begin Resmetirom Phase 3 Trial, Asks for BE Data First Parthika Patel27 July 2025 4:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central Drugs Standard Control Organisation...
Troikaa's Fast-Acting Paracetamol Shot Hits Regulatory Hurdle, CDSCO Panel Seeks More Data Dr. Divya Colin27 July 2025 3:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has asked Troikaa Pharmaceuticals Ltd. to...
CDSCO Panel Seeks Safety Data on 5% Lenalidomide TDS Before Clearing 8% Patch Trial Parthika Patel25 July 2025 4:38 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control Organisation (CDSCO) has not granted...
CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibb's Mavacamten Study Parthika Patel24 July 2025 6:49 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...
Eris Gets CDSCO Panel Nod To Dapagliflozin-Bisoprolol-Sacubitril Valsartan Combo Kit, Phase IV Trial Mandated Parthika Patel23 July 2025 7:41 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...
CDSCO Panel Clears Cipla's Glycopyrronium-Formoterol Inhaler for Phase IV Trial Dr. Divya Colin23 July 2025 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted Cipla Limited approval to...
Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDC Parthika Patel22 July 2025 6:19 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...
1-Year Ban for Fake Docs, Mandatory Disposal of Near-Expiry Stock: CDSCO Revises Pharma Export Rules Farhat Nasim21 July 2025 11:51 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a revised guidance document detailing the procedure for the issuance of...
CDSCO Panel Nod To MSD's Sotatercept Label Change, Expands Prescribing Rights to Cardiologists Parthika Patel21 July 2025 10:32 PM ISTNew Delhi: The Subject Expert Committee (SEC) under Central Drugs Standard Control Organisation's (CDSCO) Cardiovascular division has approved MSD...
